292 related articles for article (PubMed ID: 30634961)
1. Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review.
Hayton C; Terrington D; Wilson AM; Chaudhuri N; Leonard C; Fowler SJ
Respir Res; 2019 Jan; 20(1):7. PubMed ID: 30634961
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.
Fois AG; Paliogiannis P; Sotgia S; Mangoni AA; Zinellu E; Pirina P; Carru C; Zinellu A
Respir Res; 2018 Mar; 19(1):51. PubMed ID: 29587761
[TBL] [Abstract][Full Text] [Related]
3. Molecular breath analysis supports altered amino acid metabolism in idiopathic pulmonary fibrosis.
Gaugg MT; Engler A; Bregy L; Nussbaumer-Ochsner Y; Eiffert L; Bruderer T; Zenobi R; Sinues P; Kohler M
Respirology; 2019 May; 24(5):437-444. PubMed ID: 30681243
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath condensate as a potential biomarker tool for idiopathic pulmonary fibrosis-a pilot study.
Rindlisbacher B; Strebel C; Guler S; Kollár A; Geiser T; Martin Fiedler G; Benedikt Leichtle A; Bovet C; Funke-Chambour M
J Breath Res; 2017 Nov; 12(1):016003. PubMed ID: 28775244
[TBL] [Abstract][Full Text] [Related]
5. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
6. The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review.
Terrington DL; Hayton C; Peel A; Fowler SJ; Fraser W; Wilson AM
J Breath Res; 2019 Jun; 13(3):036015. PubMed ID: 30901768
[TBL] [Abstract][Full Text] [Related]
7. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
8. Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis: A pilot study.
Majewski S; Tworek D; Szewczyk K; Kurmanowska Z; Antczak A; Górski P; Piotrowski WJ
Clin Respir J; 2019 Oct; 13(10):652-656. PubMed ID: 31392802
[TBL] [Abstract][Full Text] [Related]
9. Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis.
Cameli P; Bergantini L; Salvini M; Refini RM; Pieroni M; Bargagli E; Sestini P
Nitric Oxide; 2019 Aug; 89():41-45. PubMed ID: 31054949
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress-linked biomarkers in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Paliogiannis P; Fois AG; Collu C; Bandinu A; Zinellu E; Carru C; Pirina P; Mangoni AA; Zinellu A
Biomark Med; 2018 Oct; 12(10):1175-1184. PubMed ID: 30191745
[TBL] [Abstract][Full Text] [Related]
11. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.
Malli F; Bardaka F; Tsilioni I; Karetsi E; Gourgoulianis KI; Daniil Z
Food Chem Toxicol; 2013 Nov; 61():160-3. PubMed ID: 23702326
[TBL] [Abstract][Full Text] [Related]
12. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis.
Psathakis K; Mermigkis D; Papatheodorou G; Loukides S; Panagou P; Polychronopoulos V; Siafakas NM; Bouros D
Eur J Clin Invest; 2006 May; 36(5):362-7. PubMed ID: 16634841
[TBL] [Abstract][Full Text] [Related]
13. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
[TBL] [Abstract][Full Text] [Related]
14. The Potential Role of Airways Periostin in the Clinical Practice of Patients Affected by Idiopathic Pulmonary Fibrosis.
Carpagnano GE; Soccio P; Scioscia G; Palladino GP; Foschino Barbaro MP; Lacedonia D
Rejuvenation Res; 2021 Aug; 24(4):302-306. PubMed ID: 33749341
[TBL] [Abstract][Full Text] [Related]
15. Exhaled breath condensate (EBC) biomarkers in pulmonary fibrosis.
Chow S; Thomas PS; Malouf M; Yates DH
J Breath Res; 2012 Mar; 6(1):016004. PubMed ID: 22233623
[TBL] [Abstract][Full Text] [Related]
16. Exploring breath biomarkers in BLM-induced pulmonary fibrosis mice with associative ionization time-of-flight mass spectrometry.
Wu X; Li Z; Shu J; Lu Z; Gao J; Yang B; Jiang K; Guo Y; Huang J
Talanta; 2022 Mar; 239():123120. PubMed ID: 34864537
[TBL] [Abstract][Full Text] [Related]
17. Exhaled nitric oxide in interstitial lung diseases.
Cameli P; Bargagli E; Refini RM; Pieroni MG; Bennett D; Rottoli P
Respir Physiol Neurobiol; 2014 Jun; 197():46-52. PubMed ID: 24703971
[TBL] [Abstract][Full Text] [Related]
18. Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis.
Lehtonen H; Oksa P; Lehtimäki L; Sepponen A; Nieminen R; Kankaanranta H; Saarelainen S; Järvenpää R; Uitti J; Moilanen E
Thorax; 2007 Jul; 62(7):602-7. PubMed ID: 17251310
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of some pulmonary diseases in exhaled breath.
Kharitonov SA; Barnes PJ
Biomarkers; 2002; 7(1):1-32. PubMed ID: 12101782
[TBL] [Abstract][Full Text] [Related]
20. Exhaled nitric oxide is not increased in pulmonary sarcoidosis.
Cameli P; Barbagli E; Rottoli P
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Mar; 33(1):39-40. PubMed ID: 27055834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
